I now have sufficient material from the textbooks (Sleisenger & Fordtran's GI and Liver Disease; Goodman & Gilman's Pharmacological Basis of Therapeutics; Frameworks for Internal Medicine; Bailey & Love's Surgery) plus my knowledge base to write comprehensive 5-mark answers. Let me compose all answers now.
GI Disturbances - 5 Mark Answers
1. GI Disturbances - Detailed Explanation
Gastrointestinal (GI) disturbances refer to a group of disorders and symptoms arising from dysfunction of any part of the alimentary tract - from the mouth to the anus - as well as associated organs like the liver, pancreas, and gallbladder.
Classification of GI Disturbances
A. Symptoms-Based:
| Symptom | Description |
|---|
| Nausea | Unpleasant urge to vomit without actual expulsion |
| Vomiting | Forceful expulsion of stomach contents |
| Diarrhea | Loose, watery stools >3 times/day |
| Constipation | Infrequent, hard stools; difficult defecation |
| Dyspepsia | Upper abdominal discomfort, bloating, early satiety |
| Heartburn/GERD | Retrosternal burning from acid reflux |
| Flatulence | Excessive gas accumulation/passage |
| Abdominal pain | Cramping, colicky, or persistent pain |
B. Disease-Based Classification:
- Upper GI: Peptic ulcer disease (PUD), GERD, gastritis, hiatus hernia
- Small intestinal: Malabsorption syndromes, celiac disease, Crohn's disease
- Large intestinal: Irritable Bowel Syndrome (IBS), ulcerative colitis, diverticulitis, colorectal carcinoma
- Hepatic/Biliary: Hepatitis, cirrhosis, gallstones, cholecystitis
- Pancreatic: Pancreatitis, pancreatic carcinoma
- Infections: Gastroenteritis, food poisoning, worm infestations
- Functional: No structural cause found (IBS, functional dyspepsia)
Common Causes
- Dietary indiscretion (spicy food, alcohol, overeating)
- Infections (bacterial, viral, parasitic)
- Drugs (NSAIDs, antibiotics, steroids)
- Stress and psychological factors
- Motility disorders
- Obstruction (mechanical or functional)
General Principles of Management
- Dietary modification - bland, low-fat, easily digestible diet
- Hydration and ORS (especially in diarrhea/vomiting)
- Symptomatic drug therapy (antacids, antiemetics, antidiarrhoeals, laxatives)
- Specific treatment of the underlying cause
- Referral to gastroenterologist for persistent or alarm symptoms
Sleisenger and Fordtran's Gastrointestinal and Liver Disease; Frameworks for Internal Medicine
2. Diarrhea
Definition
Diarrhea is defined as the passage of more than 3 loose or watery stools per day, or a stool weight exceeding 200 g/day. It is one of the most common GI complaints worldwide.
Types
| Type | Duration |
|---|
| Acute diarrhea | < 2 weeks |
| Persistent diarrhea | 2-4 weeks |
| Chronic diarrhea | > 4 weeks |
Mechanisms (Pathophysiology)
The causes of diarrhea operate through four main mechanisms:
- Secretory diarrhea - Increased secretion of fluid/electrolytes into the intestinal lumen (e.g., cholera toxin, VIPoma). Persists even with fasting.
- Osmotic diarrhea - Non-absorbable solutes in the gut lumen draw water osmotically (e.g., magnesium antacids, lactose intolerance). Stops with fasting.
- Exudative/Inflammatory diarrhea - Mucosal damage causes blood and pus in stools (e.g., ulcerative colitis, dysentery).
- Dysmotility diarrhea - Hypermotility reduces transit time, preventing fluid reabsorption (e.g., IBS, hyperthyroidism, diabetic autonomic neuropathy).
Causes
- Infectious: Bacteria (E. coli, Salmonella, Shigella, Vibrio cholerae), Viruses (Rotavirus, Norovirus), Parasites (Giardia, Entamoeba)
- Non-infectious: IBD, IBS, food intolerance (lactose), malabsorption, drugs (antibiotics - C. difficile, metformin)
- Other: Thyrotoxicosis, radiation enteritis, short bowel syndrome
Clinical Features
- Loose/watery stools, increased frequency
- Abdominal cramps and bloating
- Tenesmus (in dysentery)
- Fever (in infectious causes)
- Dehydration: dry mouth, reduced urine output, sunken eyes, hypotension
Treatment
- Rehydration: ORS (Oral Rehydration Solution) - first priority; IV fluids in severe dehydration.
- Dietary advice: BRAT diet (Banana, Rice, Apple, Toast); avoid dairy initially.
- Antidiarrhoeals: Loperamide (reduces intestinal motility); NOT used in bloody/infectious diarrhea.
- Antibiotics: Only for confirmed bacterial causes - Cotrimoxazole (traveller's diarrhea), Metronidazole (Giardia, C. difficile), Ciprofloxacin.
- Probiotics: Lactobacillus supplements help restore gut flora.
- Zinc supplementation: Especially in children with acute diarrhea (WHO recommendation).
Frameworks for Internal Medicine; The Essentials of Forensic Medicine and Toxicology
3. Dyspepsia
Definition
Dyspepsia is a term used to describe persistent or recurring upper abdominal discomfort or pain that is centered in the upper abdomen. It is also called "indigestion."
Types
1. Organic Dyspepsia: Has an identifiable structural or biochemical cause:
- Peptic ulcer disease (PUD)
- Gastroesophageal Reflux Disease (GERD)
- H. pylori gastritis
- Gastric carcinoma
- NSAID use
- Pancreatic/biliary disease
2. Functional (Non-ulcer) Dyspepsia: No identifiable structural cause despite investigations. Defined by Rome IV criteria as presence of one or more of:
- Postprandial fullness
- Early satiation (feeling full after small amount of food)
- Epigastric pain
- Epigastric burning
- ...in the absence of structural disease
Sub-types of Functional Dyspepsia
- Postprandial Distress Syndrome (PDS): Meal-induced symptoms - fullness and early satiety
- Epigastric Pain Syndrome (EPS): Pain/burning in epigastrium not exclusively with meals
Symptoms
- Bloating and fullness after meals
- Belching and flatulence
- Heartburn and acid regurgitation
- Nausea (with or without vomiting)
- Epigastric discomfort or pain
Alarm Features (Red Flags - Require Urgent Investigation)
- Age > 55 years with new-onset dyspepsia
- Unexplained weight loss
- Persistent vomiting
- Dysphagia (difficulty swallowing)
- GI bleeding or iron-deficiency anemia
- Palpable epigastric mass
Treatment
- Lifestyle modification: Small frequent meals; avoid spicy/fatty foods, alcohol, NSAIDs, smoking
- Antacids: Aluminum hydroxide, magnesium hydroxide - for symptomatic relief
- H2-receptor antagonists: Ranitidine, Famotidine - reduce acid secretion
- Proton Pump Inhibitors (PPIs): Omeprazole, Pantoprazole - first-line for EPS type functional dyspepsia and PUD
- H. pylori eradication: Triple therapy (PPI + Amoxicillin + Clarithromycin for 14 days) if H. pylori positive
- Prokinetics: Domperidone, Metoclopramide - for PDS type; improve gastric motility and emptying
- Antidepressants: Low-dose tricyclic antidepressants (TCAs) in refractory functional dyspepsia
Goodman & Gilman's Pharmacological Basis of Therapeutics
4. Common Drug Therapy for Pain
Pain is a major symptom accompanying many GI and non-GI conditions. The WHO analgesic ladder guides therapy.
WHO Analgesic Ladder (3-Step Approach)
- Step 1 - Mild pain: Non-opioid analgesics
- Step 2 - Moderate pain: Weak opioids ± non-opioids
- Step 3 - Severe pain: Strong opioids ± non-opioids
Drug Classes
1. Non-Opioid Analgesics
| Drug | Mechanism | Use | Dose |
|---|
| Paracetamol (Acetaminophen) | COX inhibition in CNS; unknown peripheral | Mild-moderate pain, fever | 500-1000 mg 4-6 hourly |
| Aspirin | Non-selective COX inhibitor | Mild pain, anti-platelet | 325-650 mg 4-6 hourly |
| Ibuprofen | Non-selective COX inhibitor (NSAID) | Mild-moderate pain, inflammation | 400-600 mg TDS |
| Diclofenac | Preferential COX-2 inhibitor | Musculoskeletal, GI pain | 50 mg BD/TDS |
| Celecoxib | Selective COX-2 inhibitor | Arthritis; safer on stomach | 100-200 mg BD |
Important: NSAIDs cause GI ulceration, bleeding, and renal toxicity. Should be taken with food or with a PPI.
2. Weak Opioids (Step 2)
- Codeine (30-60 mg): Also antidiarrheal and antitussive
- Tramadol (50-100 mg): Mixed opioid + SNRI mechanism; less constipating
3. Strong Opioids (Step 3)
- Morphine - gold standard for severe pain; 5-10 mg SC/IV or 10-30 mg oral
- Oxycodone, Fentanyl, Buprenorphine - alternative strong opioids
4. Adjuvant Analgesics
- Antidepressants (Amitriptyline) - neuropathic pain
- Anticonvulsants (Gabapentin, Pregabalin) - neuropathic, cancer pain
- Corticosteroids - inflammatory pain, tumor-related pain
- Antispasmodics (Dicyclomine, Hyoscine butylbromide) - GI colic/spasm
5. Antacids and PPIs for GI Pain
- For pain from PUD/GERD - PPIs (Omeprazole) are first-line
- Antacids (Aluminium hydroxide + Magnesium hydroxide) for immediate symptomatic relief
5. Vomiting
Definition
Vomiting (emesis) is the forceful oral expulsion of gastric contents through coordinated contraction of abdominal muscles, descent of the diaphragm, and relaxation of the upper esophageal sphincter. It is preceded by nausea and retching.
Pathophysiology
The vomiting reflex is coordinated by the vomiting center in the medulla oblongata. Key neural pathways involved:
- Chemoreceptor Trigger Zone (CTZ): Located in the area postrema (floor of 4th ventricle), outside the blood-brain barrier. Detects circulating toxins, drugs, metabolic abnormalities. Rich in D2, 5-HT3, NK1, and mu-opioid receptors.
- Vagal afferents: From the GI tract (enterochromaffin cells release 5-HT3 in response to irritants)
- Vestibular apparatus: Motion sickness; H1 and M1 receptors
- Cerebral cortex: Emotional, anticipatory vomiting
As per Sleisenger & Fordtran, the mechanism involves: stimulation of 5-HT3 receptors → dopamine release → D2 receptor activation in brainstem → emetic sequence.
Causes
| Category | Examples |
|---|
| GI causes | Gastroenteritis, peptic ulcer, intestinal obstruction, appendicitis |
| Central/neurological | Raised ICP, migraine, meningitis |
| Metabolic | Uraemia, diabetic ketoacidosis, Addison's disease |
| Drugs | Opioids, chemotherapy, digoxin, antibiotics |
| Pregnancy | Hyperemesis gravidarum, morning sickness |
| Vestibular | Motion sickness, labyrinthitis, Meniere's disease |
| Psychogenic | Anxiety, anorexia nervosa, bulimia |
Clinical Features
- Nausea preceding vomiting
- Retching (reverse peristalsis without expulsion)
- Actual vomiting - projectile in pyloric stenosis/raised ICP
- Dehydration, electrolyte imbalance (hypokalemia, metabolic alkalosis)
- Mallory-Weiss tear with repeated severe vomiting
Treatment
- Identify and treat the cause
- Rehydration - oral or IV fluids
- Antiemetics (see Q11 below)
- Dietary modification - small, frequent, light meals; avoid strong smells
- NG tube - if vomiting is intractable or obstruction is present
6. Constipation
Definition
Constipation is defined as having fewer than 3 bowel movements per week, with hard, dry stools that are difficult to pass, often accompanied by straining, a sensation of incomplete evacuation, or the need for manual maneuvers.
Causes
Primary (Functional/Idiopathic):
- Inadequate dietary fiber and fluid intake
- Sedentary lifestyle
- IBS-constipation dominant type (IBS-C)
- Slow transit constipation (colonic inertia)
- Pelvic floor dysfunction / dyssynergic defecation
Secondary (Organic):
- Structural: Colorectal carcinoma, strictures, anal fissure, hemorrhoids
- Endocrine: Hypothyroidism, hypercalcemia, diabetes mellitus
- Neurological: Parkinson's disease, spinal cord injury, multiple sclerosis
- Drugs: Opioids, antacids (aluminum), anticholinergics, iron supplements, calcium channel blockers
- Metabolic: Hypokalemia, dehydration
Clinical Features
- Infrequent, hard, pellet-like stools
- Straining at defecation
- Feeling of incomplete emptying
- Abdominal distension and discomfort
- Overflow diarrhea (liquid stool passes around impacted feces)
Complications
- Hemorrhoids and anal fissures
- Fecal impaction
- Rectal prolapse
- Stercoral ulcer and perforation (in severe chronic cases)
Treatment
Non-pharmacological:
- Increase dietary fiber (25-30 g/day) - fruits, vegetables, whole grains
- Adequate hydration (8 glasses/day)
- Regular exercise
- Respond promptly to the urge to defecate (do not delay)
- Biofeedback therapy (for pelvic floor dysfunction)
Pharmacological - Laxatives:
| Type | Drug | Mechanism |
|---|
| Bulk-forming | Isabgol (Psyllium), Methylcellulose | Absorb water, increase stool bulk; mimic dietary fiber |
| Osmotic | Lactulose, Polyethylene glycol (PEG), Magnesium salts | Draw water into bowel lumen osmotically |
| Stimulant/Irritant | Senna, Bisacodyl, Castor oil | Stimulate intestinal peristalsis; irritate mucosal nerves |
| Stool softeners | Docusate sodium | Surfactant; softens stools by emulsification |
| Lubricant | Liquid paraffin | Lubricates and softens stool |
| Prokinetics | Prucalopride (5-HT4 agonist) | Increases colonic transit - for refractory chronic constipation |
7. Worm Infestations
Introduction
Worm (helminthic) infestations are among the most common infections worldwide, particularly in tropical and developing countries. They affect the GI tract primarily and can lead to nutritional deficiencies, anemia, and growth retardation.
Types of Worms and Their Features
A. Roundworms (Nematodes)
| Worm | Disease | Route of Infection | Key Feature |
|---|
| Ascaris lumbricoides | Ascariasis | Feco-oral (ingestion of embryonated eggs) | Largest intestinal nematode; larvae migrate via lungs (Loeffler's syndrome) |
| Enterobius vermicularis | Enterobiasis (Pinworm/Threadworm) | Feco-oral; auto-infection | Intense perianal itching at night; common in children |
| Trichuris trichiura | Trichuriasis (Whipworm) | Feco-oral | Rectal prolapse in heavy infection |
| Hookworms (Ancylostoma, Necator) | Hookworm disease | Skin penetration (larvae in soil) | Iron-deficiency anemia; ground itch |
| Strongyloides stercoralis | Strongyloidiasis | Skin penetration | Hyperinfection syndrome in immunocompromised |
B. Tapeworms (Cestodes)
| Worm | Disease | Route |
|---|
| Taenia solium | Taeniasis / Cysticercosis | Eating undercooked pork |
| Taenia saginata | Taeniasis | Eating undercooked beef |
| Echinococcus | Hydatid disease | Dog feces contamination |
C. Flukes (Trematodes)
- Schistosoma - bilharzia; enters through skin in contaminated water
Symptoms
- Abdominal pain and cramps
- Nausea, vomiting, diarrhea
- Malnutrition, weight loss, growth retardation (in children)
- Anemia (hookworm)
- Perianal itching (pinworm)
- Intestinal obstruction (heavy Ascaris load)
- Jaundice and cholangitis (if worms block bile duct - Ascaris)
Diagnosis
- Stool examination for ova and cysts
- Scotch tape test (perianal swab) for Enterobius
- Blood: Eosinophilia, raised IgE
- Serology and imaging for tissue helminths
Treatment - Anthelmintic Drugs
| Drug | Effective Against | Dose |
|---|
| Mebendazole | Ascaris, Hookworm, Pinworm, Whipworm | 100 mg BD x 3 days or single 500 mg dose |
| Albendazole | Broad spectrum (most GI worms, cysticercosis) | 400 mg single dose; 400 mg BD x 28 days for cysticercosis |
| Pyrantel pamoate | Ascaris, Hookworm, Pinworm | 10 mg/kg single dose |
| Piperazine | Ascaris (causes flaccid paralysis of worm) | 75 mg/kg single dose |
| Niclosamide | Tapeworms | 2 g single dose |
| Praziquantel | Tapeworms, Schistosoma | 10-25 mg/kg single/divided doses |
| Ivermectin | Strongyloides, Filarial worms | 200 mcg/kg single dose |
Prevention
- Proper sanitation and safe water
- Washing hands before food and after toilet
- Wearing footwear (to prevent hookworm skin penetration)
- Cooking meat thoroughly
- Regular deworming programs (WHO recommends biannual Albendazole/Mebendazole for at-risk children)
8. Pyrexia (Fever)
Definition
Pyrexia (fever) is defined as an elevation of body temperature above normal. The normal range is 36.5-37.5°C (97.7-99.5°F). Fever is defined as an oral temperature >37.8°C (100°F) or rectal temperature >38.2°C (100.8°F).
Hyperpyrexia = temperature >41°C (105.8°F) - medical emergency
Pathophysiology
- Exogenous pyrogens (bacteria, viruses, fungi, toxins) stimulate macrophages
- Macrophages release endogenous pyrogens - mainly IL-1, IL-6, TNF-alpha, IFN-gamma
- These act on the hypothalamic thermoregulatory centre (anterior hypothalamus)
- Stimulate production of Prostaglandin E2 (PGE2) via COX-2 enzyme
- PGE2 raises the hypothalamic set-point
- Body generates heat through shivering, vasoconstriction, and increased metabolism
- Result: elevated core body temperature = fever
Causes
| Category | Examples |
|---|
| Infections | Malaria, typhoid, pneumonia, UTI, meningitis, TB |
| Non-infectious inflammation | SLE, rheumatoid arthritis, vasculitis, gout |
| Neoplasia | Lymphoma, renal cell carcinoma, leukemia ("B symptoms") |
| Drugs | Drug fever (penicillins, sulfonamides, phenytoin) |
| Endocrine | Thyroid storm, Addisonian crisis |
| CNS causes | Hypothalamic lesions, stroke |
| Post-operative/post-transfusion | |
Stages of Fever
- Onset (cold stage): Vasoconstriction, shivering, piloerection ("chills")
- Fastigium (hot stage): Stable elevated temperature; flushed, dry skin
- Defervescence (sweating stage): Temperature falls; profuse sweating, vasodilation
Patterns of Fever
- Intermittent (quotidian): Peaks daily, returns to normal - malaria
- Remittent: Fluctuates but does not return to normal - typhoid
- Continued/Sustained: Minimal variation <1°C - lobar pneumonia
- Hectic (septic): Swinging high fever - sepsis, abscess
- Pel-Ebstein: Alternating periods of fever and apyrexia - Hodgkin's lymphoma
- Relapsing: Recurrent bouts - Brucellosis, Borrelia
Clinical Features
- Elevated temperature; flushed face
- Tachycardia (10 bpm rise per 1°C rise in temperature - Liebermeister's rule)
- Rigor (severe chills with chattering teeth)
- Headache, myalgia, malaise
- Sweating during defervescence
- Febrile convulsions (especially in children 6 months - 5 years)
- Dehydration
Treatment
Non-pharmacological:
- Tepid sponging
- Adequate hydration
- Rest
Pharmacological - Antipyretics:
| Drug | Mechanism | Dose |
|---|
| Paracetamol | Inhibits central PGE2 synthesis | 500-1000 mg 4-6 hourly (adult); 10-15 mg/kg in children |
| Aspirin | Non-selective COX inhibitor | 325-650 mg; avoid in children <12 yrs (Reye's syndrome risk) |
| Ibuprofen | COX inhibitor (NSAID) | 400 mg TDS |
| Naproxen | COX inhibitor | 250-500 mg BD |
Treat the underlying cause (antibiotics for infection, antimalarials for malaria, etc.)
9. Nausea
Definition
Nausea is the unpleasant, subjective feeling or urge to vomit without actual expulsion of stomach contents. It is a symptom, not a disease, and often precedes vomiting.
Pathophysiology
Nausea requires intact neural circuits in the supratentorial regions of the brain. Although it shares some neural pathways with vomiting (particularly vagal afferents to the nucleus tractus solitarius), nausea can occur independently - even after bilateral vagotomy - indicating separate pathways.
Key neurotransmitters involved:
- 5-HT3 (serotonin) - activated by GI irritants; key target for antiemetics (ondansetron)
- Dopamine D2 - CTZ activation
- H1 (histamine) - vestibular nausea
- M1 (muscarinic) - motion sickness, pregnancy nausea
- NK1 (neurokinin 1/substance P) - delayed nausea from chemotherapy
Causes
- GI: Gastroenteritis, PUD, GERD, hepatitis, pancreatitis, intestinal obstruction
- Drugs: Opioids, cytotoxics (chemotherapy), NSAIDs, antibiotics, digoxin
- Metabolic: Uraemia, DKA, hypercalcemia, Addison's disease
- Pregnancy: Morning sickness (first trimester); Hyperemesis gravidarum (severe)
- Neurological: Migraine, raised ICP, vestibular disorders
- Psychogenic: Anxiety, eating disorders
- Postoperative: Post-anaesthesia nausea and vomiting (PONV)
Clinical Features
- Unpleasant "sick" feeling in the upper abdomen/throat
- Pallor, diaphoresis (sweating)
- Hypersalivation and tachycardia
- Anorexia
- May be followed by retching and vomiting
Treatment
- Address the cause (stop offending drug, treat infection, etc.)
- Dietary advice: Small, frequent, bland meals; ginger tea; cold foods (less odor)
- Hydration: Sips of clear fluids, ORS
- Antiemetics: (see Q11)
- Acupressure: P6 (Nei Guan) wristband; evidence for pregnancy nausea
- Ginger (Zingiber officinale): Evidence shows efficacy equal to metoclopramide for postoperative nausea; dose 0.5-1 g/day
Sleisenger and Fordtran's Gastrointestinal and Liver Disease
10. Ophthalmic Symptoms (Eye Symptoms)
Definition and Scope
Ophthalmic symptoms are symptoms relating to the eyes and visual system, which can arise from local (ocular) disease or as manifestations of systemic conditions.
Common Ophthalmic Symptoms
1. Redness (Red Eye)
- Causes: Conjunctivitis (bacterial/viral/allergic), subconjunctival hemorrhage, acute angle-closure glaucoma, anterior uveitis, foreign body, corneal abrasion
- Key differential: Vision-threatening causes must be excluded (glaucoma, uveitis)
2. Pain in the Eye
- Superficial pain: Corneal abrasion, foreign body, conjunctivitis
- Deep aching pain: Acute glaucoma, uveitis, scleritis, optic neuritis
- Headache with eye pain: Raised intraocular pressure (IOP)
3. Visual Disturbances
- Blurred vision: Refractive errors, cataracts, diabetic retinopathy, macular degeneration, raised ICP, optic neuritis
- Diplopia (double vision): CN VI palsy (petrous apex pathology), CN III or IV palsy, myasthenia gravis, thyroid eye disease. Diplopia on lateral gaze due to VIth nerve involvement is characteristic of petrous apex pathology.
- Loss of vision: Acute - CRAO (central retinal artery occlusion), CRVO, vitreous hemorrhage, retinal detachment; Gradual - glaucoma, cataract, ARMD
4. Watering (Epiphora)
- Excessive tearing from overflow due to blocked nasolacrimal duct or reflex lacrimation from corneal irritation.
5. Discharge
- Mucopurulent: Bacterial conjunctivitis
- Watery: Viral conjunctivitis, allergy
- Stringy/white: Allergic conjunctivitis
6. Photophobia
- Intolerance to light; associated with: Anterior uveitis, corneal ulcer, migraine, meningitis
7. Floaters and Flashes
- Floaters: Posterior vitreous detachment, vitreous hemorrhage
- Flashes (photopsia): Retinal tear/detachment - requires urgent ophthalmology referral
8. Night Blindness (Nyctalopia)
- Vitamin A deficiency, retinitis pigmentosa
9. Systemic Disease-related Ophthalmic Symptoms
- Diabetes: Blurred vision (fluctuating blood sugar), diabetic retinopathy
- Hypertension: Hypertensive retinopathy (flame hemorrhages, AV nipping)
- Thyroid disease: Proptosis, lid retraction, diplopia (thyroid eye disease)
- Rheumatoid arthritis/SLE: Dry eyes (keratoconjunctivitis sicca), scleritis, episcleritis
- Raised ICP: Papilledema, visual field defects, diplopia (false localizing CN VI palsy)
Treatment Approach
- Infections: Antibiotic eye drops (Chloramphenicol, Ciprofloxacin) for bacterial; antiviral for herpetic
- Allergic: Antihistamine drops (Sodium cromoglycate, Olopatadine), oral antihistamines
- Glaucoma: Timolol (beta-blocker) eye drops, Latanoprost (prostaglandin analogue), Acetazolamide (carbonic anhydrase inhibitor)
- Uveitis: Topical/systemic corticosteroids, cycloplegics (Atropine)
- Dry eyes: Artificial tears (Hydroxypropyl methylcellulose drops)
- Vitamin A deficiency: Vitamin A supplementation
Scott-Brown's Otorhinolaryngology Head & Neck Surgery
11. Drugs Used in the Treatment of Nausea and Vomiting
Antiemetic drugs act by blocking one or more of the receptors involved in the emetic reflex (5-HT3, D2, H1, M1, NK1).
Classification of Antiemetic Drugs
A. 5-HT3 (Serotonin) Receptor Antagonists - "Setrons"
Drugs: Ondansetron, Granisetron, Palonosetron, Dolasetron
Mechanism: Block 5-HT3 receptors in the CTZ and peripheral vagal afferents, preventing the emetic reflex triggered by serotonin release from enterochromaffin cells.
Uses:
- Chemotherapy-induced nausea and vomiting (CINV) - drug of choice for acute CINV
- Radiotherapy-induced nausea
- Post-operative nausea and vomiting (PONV)
Dose: Ondansetron 4-8 mg IV/oral; can be repeated every 8 hours
Side effects: Headache, constipation, QT prolongation
B. Dopamine D2 Receptor Antagonists
1. Metoclopramide
- Mechanism: Blocks D2 receptors in CTZ; also 5-HT3 antagonist and 5-HT4 agonist (prokinetic)
- Uses: PONV, drug-induced vomiting, diabetic gastroparesis, CINV (less effective than ondansetron)
- Dose: 10 mg oral/IV/IM 3 times daily
- Side effects: Extrapyramidal symptoms (dystonia, tardive dyskinesia with long-term use), drowsiness, galactorrhea
2. Domperidone
- Mechanism: Peripheral D2 antagonist; does NOT cross the blood-brain barrier significantly
- Uses: CINV, nausea of gastroparesis, functional dyspepsia
- Dose: 10 mg TDS before meals
- Advantage over Metoclopramide: Fewer CNS/extrapyramidal side effects
- Side effects: Cardiac arrhythmias (QT prolongation) - avoid in cardiac patients
3. Prochlorperazine
- Phenothiazine antiemetic
- Uses: Vestibular vomiting, labyrinthitis, PONV
- Dose: 5-10 mg oral/IM; 25 mg suppository
4. Haloperidol
- Butyrophenone; potent D2 antagonist
- Uses: Palliative care for refractory nausea, opioid-induced vomiting
- Dose: 1.5 mg BD oral; 0.5-2 mg SC in palliative care
C. H1 (Histamine) Receptor Antagonists - Antihistamines
Drugs: Promethazine, Dimenhydrinate, Cyclizine, Meclizine
Mechanism: Block H1 receptors and also muscarinic M1 receptors in the vestibular nuclei and vomiting center.
Uses:
- Motion sickness (first-line)
- Vestibular nausea/vomiting (labyrinthitis, Meniere's disease)
- Pregnancy nausea
Dose: Promethazine 25 mg oral/IM; Meclizine 25-50 mg
Side effects: Sedation (useful in some settings), dry mouth, urinary retention, blurred vision
D. Muscarinic M1 Receptor Antagonists (Anticholinergics)
Drugs: Hyoscine (Scopolamine), Dicyclomine
Mechanism: Block M1 muscarinic receptors in the vestibular apparatus and GI tract
Uses:
- Motion sickness (Hyoscine transdermal patch behind ear - prophylaxis)
- GI colic and nausea from smooth muscle spasm
Side effects: Dry mouth, blurred vision, urinary retention, tachycardia, confusion (elderly)
E. NK1 (Neurokinin-1) Receptor Antagonists
Drugs: Aprepitant, Fosaprepitant (IV prodrug), Rolapitant, Netupitant
Mechanism: Block Substance P/NK1 receptors in the CNS; particularly effective against delayed-phase CINV (24-120 hours post-chemotherapy)
Uses: Highly emetogenic chemotherapy (e.g., cisplatin); used in combination with ondansetron + dexamethasone
Dose: Aprepitant 125 mg on Day 1, 80 mg on Days 2-3
Side effects: Fatigue, hiccups, constipation; CYP3A4 inhibitor (drug interactions)
F. Corticosteroids
Drug: Dexamethasone
Mechanism: Unclear antiemetic mechanism; possibly prostaglandin inhibition or direct effect on CTZ
Uses: Part of combination antiemetic regimens for CINV; also PONV prophylaxis
Dose: 4-12 mg IV/oral
G. Cannabinoids
Drugs: Dronabinol (THC), Nabilone
Mechanism: Act on CB1 receptors in the dorsal vagal complex, inhibiting the emetic reflex
Uses: Refractory CINV when other antiemetics fail; appetite stimulation in cancer/HIV patients
H. Miscellaneous
| Drug | Class | Use |
|---|
| Ginger | Herbal (5-HT3 antagonist activity) | Pregnancy nausea, PONV |
| Pyridoxine (Vit B6) | Vitamin | Pregnancy-related nausea and vomiting |
| Ondansetron + Metoclopramide + Dexamethasone | Combination | Highly emetogenic CINV |
| Lorazepam | Benzodiazepine | Anticipatory CINV (anxiety-related) |
Summary Table of Antiemetics
| Drug Class | Receptor Blocked | Best Used For |
|---|
| Ondansetron (Setrons) | 5-HT3 | CINV, PONV |
| Metoclopramide | D2 + 5-HT4 (prokinetic) | PONV, gastroparesis |
| Domperidone | Peripheral D2 | Functional nausea, dyspepsia |
| Promethazine | H1 + M1 | Motion sickness, vestibular |
| Hyoscine | M1 | Motion sickness |
| Aprepitant | NK1 | Delayed CINV |
| Dexamethasone | - | CINV (combination) |
| Prochlorperazine | D2 (phenothiazine) | Vestibular, PONV |
Sleisenger and Fordtran's GI and Liver Disease; Goodman & Gilman's Pharmacological Basis of Therapeutics; Morgan and Mikhail's Clinical Anesthesiology
These answers are written as per B.Pharm/D.Pharm Pharmacology and Community Pharmacy practice curriculum (self-care and OTC therapeutics module).